GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...

According to the data, when microglia activity in the brain was suppressed, baby mice were better able to recall fearful experiences.

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

Researchers suggest that wound dressings infused with antioxidants such as catalase could be an effective future treatment.

Data from several dozen human volunteers showed that blocking sEH raised epoxy-oxylipin levels and reduced harmful immune ...

Scientists first read the human genome, a three-billion-letter biological book, in April 2003. Since then, researchers have steadily advanced the ability to write DNA, moving far beyond single-gene ...

Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...

UC San Diego leads a $25.8 million ARPA-H funded project to 3D bioprint patient-specific human livers, aiming to eliminate organ shortages.

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.

Following the closing, the Emeryville and Berkeley, CA, biologics manufacturing facilities will be transferred to Zydus.

Stopping cancer cells from entering a soft biomechanical state could help the immune system clear dormant cancer metastasis.